Fig. 4From: Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancerTumour-immune topography: Scatter plots of tumour and stromal cell densities of (A) CD3, (B) CD4, (C) CD8, (D) CD68, (E) CD79A and (F) CD163 immune cells and tumour-immune phenotype distributions are illustrated. Classification of tumour-immune phenotypes are based on median cell densities across tumour and stroma regions for each markerBack to article page